Sun Pharma to acquire Innovcare Lifesciences for $28.7 million
Sun Pharma to acquire Innovcare Lifesciences for $28.7 million June 20 (Reuters) - Sun Pharmaceutical Industries SUN.NS on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million).
($1 = 94.3200 Indian rupees)
(Reporting by Devika Nair in Bengaluru; Editing by Alexandra Hudson)
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses